ARTICLE | Product Development
Four late-stage COVID-19 vaccine trial protocols harmonized, Fauci says
Plus Regeneron and NIAID start Phase III prevention trial of antiviral mAb cocktail
July 7, 2020 1:02 AM UTC
In a live-streamed conversation, NIH director Francis Collins and NIAID director Anthony Fauci discussed progress in standardizing protocols of Phase III trials for COVID-19 vaccines, as well as the ongoing need for therapies that can treat patients after infection.
Applying the same protocols and endpoints across COVID-19 clinical trials would help ensure quality standards and greatly facilitate comparison of results...
BCIQ Target Profiles